ID

41215

Description

Proton Radiation for Lymphoma Involving Mediastinum; ODM derived from: https://clinicaltrials.gov/show/NCT01751412

Link

https://clinicaltrials.gov/show/NCT01751412

Keywords

  1. 7/17/20 7/17/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 17, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lymphoma NCT01751412

Eligibility Lymphoma NCT01751412

  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT01751412
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed hodgkin lymphoma or non-hodgkin lymphoma
Description

Hodgkin Disease | Lymphoma, Non-Hodgkin

Data type

boolean

Alias
UMLS CUI [1]
C0019829
UMLS CUI [2]
C0024305
must complete standard chemotherapy appropriate for the histologic subtype of lymphoma and be able to start radiation therapy within 3-6 weeks of completing chemotherapy
Description

Chemotherapy Completed Lymphoma Subtype | Therapeutic radiology procedure

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0205197
UMLS CUI [1,3]
C0024299
UMLS CUI [1,4]
C0449560
UMLS CUI [2]
C1522449
life expectancy of at least 12 months
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
must have achieved complete or partial response per appropriate imaging technique within 4 weeks of study entry following administration of chemotherapy
Description

In complete remission Imaging Techniques | Partial response Imaging Techniques | Status post Chemotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0677874
UMLS CUI [1,2]
C0079595
UMLS CUI [2,1]
C1521726
UMLS CUI [2,2]
C0079595
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C0392920
individuals with known history of hiv positivity must be on appropriate haart therapy
Description

HIV Seropositivity | Antiretroviral Therapy, Highly Active

Data type

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C0887947
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or breastfeeding
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
prior therapeutic radiation therapy > 200 cgy has been delivered to target volume
Description

Prior Radiation Therapy Clinical target volume

Data type

boolean

Alias
UMLS CUI [1,1]
C0279134
UMLS CUI [1,2]
C0454198
have not recovered from adverse events due to systemic agents administered more than 4 weeks earlier
Description

Adverse effect of systemic agents | Recovery Lacking

Data type

boolean

Alias
UMLS CUI [1]
C0261794
UMLS CUI [2,1]
C2004454
UMLS CUI [2,2]
C0332268
uncontrolled intercurrent illness
Description

Comorbidity Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205318
history of a different malignancy unless disease free for at least 2 years (cervical cancer in situ, basal or squamous cell carcinoma are acceptable)
Description

Cancer Other | Exception Disease Free Duration | Exception Carcinoma in situ of uterine cervix | Exception Basal cell carcinoma | Exception Squamous cell carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0012634
UMLS CUI [2,3]
C0332296
UMLS CUI [2,4]
C0449238
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0007117
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0007137
receiving any other investigational agents
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230

Similar models

Eligibility Lymphoma NCT01751412

  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT01751412
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Hodgkin Disease | Lymphoma, Non-Hodgkin
Item
histologically confirmed hodgkin lymphoma or non-hodgkin lymphoma
boolean
C0019829 (UMLS CUI [1])
C0024305 (UMLS CUI [2])
Chemotherapy Completed Lymphoma Subtype | Therapeutic radiology procedure
Item
must complete standard chemotherapy appropriate for the histologic subtype of lymphoma and be able to start radiation therapy within 3-6 weeks of completing chemotherapy
boolean
C0392920 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
C0449560 (UMLS CUI [1,4])
C1522449 (UMLS CUI [2])
Life Expectancy
Item
life expectancy of at least 12 months
boolean
C0023671 (UMLS CUI [1])
In complete remission Imaging Techniques | Partial response Imaging Techniques | Status post Chemotherapy
Item
must have achieved complete or partial response per appropriate imaging technique within 4 weeks of study entry following administration of chemotherapy
boolean
C0677874 (UMLS CUI [1,1])
C0079595 (UMLS CUI [1,2])
C1521726 (UMLS CUI [2,1])
C0079595 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C0392920 (UMLS CUI [3,2])
HIV Seropositivity | Antiretroviral Therapy, Highly Active
Item
individuals with known history of hiv positivity must be on appropriate haart therapy
boolean
C0019699 (UMLS CUI [1])
C0887947 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Prior Radiation Therapy Clinical target volume
Item
prior therapeutic radiation therapy > 200 cgy has been delivered to target volume
boolean
C0279134 (UMLS CUI [1,1])
C0454198 (UMLS CUI [1,2])
Adverse effect of systemic agents | Recovery Lacking
Item
have not recovered from adverse events due to systemic agents administered more than 4 weeks earlier
boolean
C0261794 (UMLS CUI [1])
C2004454 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
Comorbidity Uncontrolled
Item
uncontrolled intercurrent illness
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Cancer Other | Exception Disease Free Duration | Exception Carcinoma in situ of uterine cervix | Exception Basal cell carcinoma | Exception Squamous cell carcinoma
Item
history of a different malignancy unless disease free for at least 2 years (cervical cancer in situ, basal or squamous cell carcinoma are acceptable)
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0332296 (UMLS CUI [2,3])
C0449238 (UMLS CUI [2,4])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0007117 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0007137 (UMLS CUI [5,2])
Investigational New Drugs
Item
receiving any other investigational agents
boolean
C0013230 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial